Cargando…

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy

BACKGROUND: Patients with stage IV alveolar rhabdomyosarcoma (RMA) have a 5-year-survival rate not exceeding 30%. Here, we assess the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for these patients in comparison to standard-of-care regimens. We also compare the use of HLA-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schober, Sebastian Johannes, Hallmen, Erika, Reßle, Florian, Gassmann, Hendrik, Prexler, Carolin, Wawer, Angela, von Luettichau, Irene, Ladenstein, Ruth, Kazanowska, Bernarda, Ljungman, Gustaf, Niggli, Felix, Lohi, Olli, Hauer, Julia, Gruhn, Bernd, Klingebiel, Thomas, Bader, Peter, Burdach, Stefan, Lang, Peter, Sparber-Sauer, Monika, Koscielniak, Ewa, Thiel, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127413/ https://www.ncbi.nlm.nih.gov/pubmed/35619911 http://dx.doi.org/10.3389/fonc.2022.878367

Ejemplares similares

Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol
por: Koscielniak, Ewa, et al.
Publicado: (2022)

Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma
por: Scheer, Monika, et al.
Publicado: (2022)

Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials
por: Tramsen, Lars, et al.
Publicado: (2023)

Desmoplastic small round cell tumors: Multimodality treatment and new risk factors
por: Scheer, Monika, et al.
Publicado: (2019)

The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents
por: Scheer, Monika, et al.
Publicado: (2021)

Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS)
por: Urla, Cristian, et al.
Publicado: (2019)

Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
por: Thiel, U., et al.
Publicado: (2021)

Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing’s Sarcoma, Enhancing T Cell Cytotoxicity
por: Biele, Emilie, et al.
Publicado: (2021)

Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma
por: Prexler, Carolin, et al.
Publicado: (2022)

Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow
por: Thiel, Uwe, et al.
Publicado: (2016)

Higher rates of metastatic disease may explain the declining trend in Swedish paediatric rhabdomyosarcoma survival rates
por: Lychou, Sara E., et al.
Publicado: (2015)

Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma
por: Schober, Sebastian J., et al.
Publicado: (2018)

Sclerosing Epithelioid Fibrosarcoma of the Bone: A Case Report of High Resistance to Chemotherapy and a Survey of the Literature
por: Grunewald, Thomas G. P., et al.
Publicado: (2010)

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
por: Thiel, U, et al.
Publicado: (2013)

MHC Class I-Restricted TCR-Transgenic CD4(+) T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo
por: Schober, Sebastian J., et al.
Publicado: (2020)

Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma
por: Maennlin, Simon, et al.
Publicado: (2022)

CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
por: Walter, Dagmar, et al.
Publicado: (2011)

Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models
por: Rettinger, Eva, et al.
Publicado: (2012)

Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas
por: Eichholz, Thomas, et al.
Publicado: (2023)

The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells
por: Jaaks, Patricia, et al.
Publicado: (2016)

Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model
por: Hajdin, Katarina, et al.
Publicado: (2010)

T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer
por: Xue, Busheng, et al.
Publicado: (2022)

Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression
por: Scholl, F A, et al.
Publicado: (2000)

Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma
por: Satheesha, S, et al.
Publicado: (2016)

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
por: Weidenbusch, Bushra, et al.
Publicado: (2018)

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma
por: Evdokimova, Valentina, et al.
Publicado: (2022)

A complex pattern of chemokine receptor expression is seen in osteosarcoma
por: von Luettichau, Irene, et al.
Publicado: (2008)

Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity
por: Manzella, Gabriele, et al.
Publicado: (2020)

Metabolic Disturbances in Children Treated for Solid Tumors
por: Barg, Ewa, et al.
Publicado: (2019)

Caveolins in rhabdomyosarcoma
por: Rossi, Stefania, et al.
Publicado: (2011)

Relapsed Rhabdomyosarcoma
por: Heske, Christine M., et al.
Publicado: (2021)

Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013)

Trends in ferritin measurements in children and adolescents: A Finnish 9‐year observational study
por: Nikkilä, Atte, et al.
Publicado: (2022)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
por: Fischer, Kyra, et al.
Publicado: (2017)

Defining the Extracellular Matrix of Rhabdomyosarcoma
por: Lian, Xiaolei, et al.
Publicado: (2021)

Does time heal all wounds? A longitudinal study of the development of posttraumatic stress symptoms in parents of survivors of childhood cancer and bereaved parents
por: Ljungman, Lisa, et al.
Publicado: (2015)

Internet‐based guided self‐help for parents of children on cancer treatment: a randomized controlled trial
por: Cernvall, Martin, et al.
Publicado: (2015)

The significance of margins in pediatric Non‐Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)
por: Sparber‐Sauer, Monika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1v2d4elnqjkkat2fkpqskh48ef